Format

Send to

Choose Destination
Adv Chronic Kidney Dis. 2017 Jul;24(4):219-227. doi: 10.1053/j.ackd.2017.05.004.

Antibiotic Dosing in Continuous Renal Replacement Therapy.

Author information

1
Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI.
2
Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI. Electronic address: muellerb@umich.edu.

Abstract

Appropriate antibiotic dosing is critical to improve outcomes in critically ill patients with sepsis. The addition of continuous renal replacement therapy makes achieving appropriate antibiotic dosing more difficult. The lack of continuous renal replacement therapy standardization results in treatment variability between patients and may influence whether appropriate antibiotic exposure is achieved. The aim of this study was to determine if continuous renal replacement therapy effluent flow rate impacts attaining appropriate antibiotic concentrations when conventional continuous renal replacement therapy antibiotic doses were used. This study used Monte Carlo simulations to evaluate the effect of effluent flow rate variance on pharmacodynamic target attainment for cefepime, ceftazidime, levofloxacin, meropenem, piperacillin, and tazobactam. Published demographic and pharmacokinetic parameters for each antibiotic were used to develop a pharmacokinetic model. Monte Carlo simulations of 5000 patients were evaluated for each antibiotic dosing regimen at the extremes of Kidney Disease: Improving Global Outcomes guidelines recommended effluent flow rates (20 and 35 mL/kg/h). The probability of target attainment was calculated using antibiotic-specific pharmacodynamic targets assessed over the first 72 hours of therapy. Most conventional published antibiotic dosing recommendations, except for levofloxacin, reach acceptable probability of target attainment rates when effluent rates of 20 or 35 mL/kg/h are used.

KEYWORDS:

Acute kidney injury; Antibiotics; Pharmacodynamics; Pharmacokinetics; Renal replacement therapy

PMID:
28778361
DOI:
10.1053/j.ackd.2017.05.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center